2025
Verma H, Orloff J, Poplausky D, Block B, Young JN, Hu B, Piontkowski A, Rivera-Oyola R, Lalvani S, Rabinowitz G, Lambert R, Silver C, Powers C, Estrada Y, Zhou L, Suemitsu Y, Almonte D, Ekey KMY, Garcia-Barros M, Thin TH, Soto A, Brody R, Guttman-Yassky E, Brown R, Gulati N.
Safety, tolerability, and efficacy of topical diphencyprone for cutaneous neurofibromas: results from a phase I clinical trial
J Invest Dermatol. 2025 Sep
Alani O, Ahmed A, Haraldsdóttir EL, Hoyt D, Thomas S, Piontkowski AJ, Lambert R, Lewin JM, Niedt G, Sasso FP, Ungar J, Gulati N, Kristjansson AK, Jonasson JG, Sigurgeirsson B, Adalsteinsson JA.
The incidence and impact of melanoma subtypes in Iceland 1955-2023
Br J Dermatol. 2025 Sep
DOI: 10.1093/bjd/ljaf248
Jo JJ, Verma H, Alani O, Kasi A, Ayub M, Gulati N, Ahmad S.
Risk of Ophthalmologic Comorbidities in Hidradenitis Suppurativa Patients
Ocul Immunol Inflamm. 2025 Sep
David K, Rabinowitz G, Gulati N, Lamb A.
Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
J Drugs Dermatol. 2025 Sep
DOI: 10.36849/jdd.9216
Thang CJ, Levine J, Mo L, Roster K, Garate D, Talia J, Gulati N, Adalsteinsson J, Ungar B.
Cardiovascular safety of low-dose oral minoxidil in nonscarring alopecia: A multicenter population-based cohort study using TriNetX
J Am Acad Dermatol. 2025 Sep
Piontkowski AJ, Dubin C, Thakker S, Orloff J, Powers CM, Silver C, Ungar B, Gulati N.
Vitiligo and associated comorbidities: a case-control study in the All of Us database
Clin Exp Dermatol. 2025 Aug
DOI: 10.1093/ced/llaf228
Islam RK, Levine J, Maltese A, Mo L, Talia J, Gulati N, Adalsteinsson J, Lipner SR, Ungar B.
Cardiovascular Risk of JAK Inhibitors in Severe Alopecia Areata: A Multicenter Cohort Study
Clin Exp Dermatol. 2025 Aug
DOI: 10.1093/ced/llaf390
Morsia S, Pizzichetta MA, Kaleci S, Chester J, Ciardo S, Alma A, Poplausky D, Falcinelli F, Adalsteinsson JA, Rubegni P, Guttman-Yassky E, Gulati N, Pellacani G, Cinotti E, Farnetani F.
Dermoscopy and Reflectance Confocal Microscopy Improves Accuracy in Differentiating Atypical Basal Cell Carcinoma from Seborrheic Keratosis and Vice Versa
Dermatology. 2025 Aug
DOI: 10.1159/000547590
Rabinowitz G, Gulati N, Fenner J.
Flipping the Page on Skin Stigma: The Role of Children’s Books in Pediatric Dermatology
Pediatr Dermatol. 2025 Sep-Oct
DOI: 10.1111/pde.16022
Choi HS, Jung S, Kim KM, Lee M, Park JH, Hwang S, Cha SM, Young JN, Poplausky D, Nam H, Gulati N, Park CG, Kim HJ, Park JU.
CXCL16 Producing Tumor Clones Are Shaping Immunosuppressive Microenvironment in Squamous Cell Carcinoma via CXCR6 Regulatory T Cell
Cancer Med. 2025 Aug
DOI: 10.1002/cam4.71060
Levine J, Islam RK, Mo L, Gulati N, Adalsteinsson J, Talia J, Lipner SR, Ungar B.
Thromboembolism risk of Janus kinase inhibitors with concurrent oral contraceptive use: a global multicentre cohort study
Clin Exp Dermatol. 2025 Jul
DOI: 10.1093/ced/llaf178
Rabinowitz G, Okine T, Gulati N.
Between skin and psyche: Navigating mental health in the dermatology clinic
J Am Acad Dermatol. 2025 Jul
2024
Poplausky D, Block BR, Chang A, Thakker S, Young JN, Gulati N, Ungar J.
Single-institution retrospective review evaluating the impact of the Covid-19 pandemic on isotretinoin prescribing practices
J Dermatolog Treat. 2024 Dec
Powers CM, Verma H, Orloff J, Piontkowski AJ, Tiersten A, Lamb A, Gulati N.
Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report
J Dermatolog Treat. 2024 Dec
Orloff J, Patel DD, Powers CM, Piontkowski AJ, Phelps RG, Richter J, Gulati N.
Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab
JAAD Case Rep. 2024 May
O’Hagan R, Ngandjui J, Ungar B, Ungar J, Gulati N.
A Survey of Demographics and Treatments in Melanoma Case Reports: Retrospective Bibliometric Analysis
JMIR Dermatol. 2024 Apr
DOI: 10.2196/56684
Brüggen MC, Traidl S, Mitamura Y, Walsh S, French LE, Gulati N, Phillips E, Maverakis E, Ingen-Housz-Oro S.
Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients
Allergy. 2024 Apr
DOI: 10.1111/all.16122
Powers CM, Piontkowski AJ, Block BR, Orloff J, Guttman-Yassky E, Gulati N.
Pemphigoid and atopy: A case-control study in the All of Us database.
J Allergy Clin Immunol Pract. 2024 Apr
Powers CM, Piontkowski AJ, Orloff J, Pulsinelli J, Uddin FB, Correa Da Rosa J, Ungar B, Gulati N.
Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
J Am Acad Dermatol. 2024 Apr
Obi A, McKinley J, Oladunjoye E, Williams A, Li V, Wu J, Yang C, Darwin E, Gulati N, Haskin A, Correa da Rosa J, Svidzinski C.
Doxycycline for central centrifugal cicatricial alopecia: A single center retrospective analysis.
J Am Acad Dermatol. 2024 Mar
Agarwal A, Gulati N.
Characterizing Occupational Skin Disease Incidence, 2017-2021.
Dermatitis. 2024 Mar-Apr
Pagan AD, Obi A, McKinley J, Oladunjoye E, Kasago I, Gulati N, Phelps RG, Svidzinski C.
Birt-Hogg-Dubé syndrome in skin of color: Literature review.
J Am Acad Dermatol. 2024 Feb
Faldetta C, Kaleci S, Chester J, Ruini C, Ciardo S, Manfredini M, Guida S, Chello C, Cantisani C, Young JN, Cabral P, Gulati N, Guttman-Yassky E, Pellacani G, Farnetani F.
Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy.
J Am Acad Dermatol. 2024 Feb
Poplausky D, Piontkowski AJ, Phelps RG, Gulati N.
Microcystic lymphatic malformation following a double mastectomy.
JAAD Case Rep. 2024 Feb
Navrazhina K, Garcet S, Williams SC, Gulati N, Kiecker F, Frew JW, Mitsui H, Krueger JG.
Laser capture microdissection provides a novel molecular profile of human primary cutaneous melanoma.
Pigment Cell Melanoma Res. 2024 Jan
DOI: 10.1111/pcmr.13121
Luu Y, Han J, Agarwal A, Elkady N, Jaroonwanichkul S, Gulati N, Gittler J.
Risk for second primary cancers among pediatric and young adult melanoma survivors.
Pediatr Dermatol. 2024 Jan-Feb
DOI: 10.1111/pde.15421
Young JN, Verma H, El Kashlan N, Poplausky D, Lamb AJ, Guttman-Yassky E, Gulati N.
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study.
JAAD Case Rep. 2024 Jan
Young JN, Rivera-Oyola R, Poplausky D, Suemitsu Y, Kim RH, Doroshow D, Gulati N.
A case of urticarial vasculitis associated with atezolizumab
JAAD Case Rep. 2024 Jan
See Dr. Gulati’s other publications: https://www.ncbi.nlm.nih.gov/myncbi/1zEpcIl4gs75l/bibliography/public/